anonymous
Guest
anonymous
Guest
Galderma is a Swiss company. The listing in Switzerland makes sense. Drop the US blinker.Listing anywhere but the US was a failure. The US SEC is far more scrupulous in terms of due diligence than the Swiss exchange, and one wonders why FO couldn’t get a top tier US bank to run the IPO. That said, the current pricing is irrelevant until the lock-ups for investors are expired.